BioHealth News Archive

AstraZeneca and Daiichi Sankyo Sign $6.9 Billion Deal for a Single Cancer Drug | BioSpace

AstraZeneca and Daiichi Sankyo Sign $6.9 Billion Deal for a Single Cancer Drug | BioSpace

AstraZeneca signed a global development and commercialization deal with Daiichi Sankyo for trastuzumab deruxtecan (DS-8201), an antibody-drug conjugate (ADC). An ADC is a chemotherapy…

Read More
Innovators – Deadline Extended to April 9th for $250K Pediatric Device Competition

Innovators – Deadline Extended to April 9th for $250K Pediatric Device Competition

Pediatric orthopedic and spine medical device innovators –good news---the deadline has been extended until Tues., April 9 at midnight EST to apply for the…

Read More
Creatv MicroTech’s Liquid Cell Biopsy and CAML cancer biomarker featured at AACR 2019 – Press Release

Creatv MicroTech’s Liquid Cell Biopsy and CAML cancer biomarker featured at AACR 2019 – Press Release

Creatv MicroTech, detecting and diagnosing cancer when it matters most, will present its latest findings on cancer diagnosis and treatment at the Annual American…

Read More
AstraZeneca to help build new life science research cluster in China | FierceBiotech

AstraZeneca to help build new life science research cluster in China | FierceBiotech

AstraZeneca has signed on to be a founding partner for a new life sciences research hub in China, to be housed just west of…

Read More
FDA CBER director Peter Marks on developing rare disease gene therapies – Business Insider

FDA CBER director Peter Marks on developing rare disease gene therapies – Business Insider

These are boom times for gene therapy, an innovative type of medicine that works to treat disease at the genetic level to offer a…

Read More
BrainScope Completes Large-Scale Clinical Studies of Concussion in Universities, High Schools and Concussion Clinics — BrainScope

BrainScope Completes Large-Scale Clinical Studies of Concussion in Universities, High Schools and Concussion Clinics — BrainScope

BrainScope®, a medical neuro-technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, announced today that it had concluded both algorithm development…

Read More
Useful Stats: Sources of funds for R&D at colleges and universities, by state | SSTI

Useful Stats: Sources of funds for R&D at colleges and universities, by state | SSTI

Outside of the private sector, colleges and universities perform the vast majority of R&D in the United States – but where do these funds…

Read More
PowerTen: Spend 10 Minutes with Baltimore’s Innovation Leaders

PowerTen: Spend 10 Minutes with Baltimore’s Innovation Leaders

Thursday, July 19, 20184:30 - 7:00 PM EST Spend an inspiring 10 minute ‘ideastorming’ session with the some of the most influential innovation leaders…

Read More
Dr. Kurt Newman @ Children’s National Health System – Innovations in Pediatrics by The #PopHealth Show

Dr. Kurt Newman @ Children’s National Health System – Innovations in Pediatrics by The #PopHealth Show

Join us today as we speak with Dr. Kurt Newman from Children's National Health System about innovations in pediatrics. {iframe}https://soundcloud.com/pophealth/kurt-newman{/iframe}

Read More
Fina Biosolutions’ Licensee Successfully Completes a Phase 3 Study and Enters World Health Organization (WHO) Registration for Pneumosil® | Business Wire

Fina Biosolutions’ Licensee Successfully Completes a Phase 3 Study and Enters World Health Organization (WHO) Registration for Pneumosil® | Business Wire

Fina Biosolutions is pleased to announce that the Serum Institute of India Private Limited (SIIPL), has completed a Phase 3 study for Pneumosil® a…

Read More
The Region’s Leaders are Talking About the Capital CoLAB

The Region’s Leaders are Talking About the Capital CoLAB

Last week, the Greater Washington Partnership (the Partnership) and Business Roundtable (BRT) held an event showcasing the Capital CoLAB (Collaborative of Leaders in Academia…

Read More
Thermo Fisher to buy gene therapy contract manufacturer Brammer Bio for $1.7B – MedCity News

Thermo Fisher to buy gene therapy contract manufacturer Brammer Bio for $1.7B – MedCity News

A company that makes products for science researchers has bought one of the largest contract manufacturers of viral vectors for gene therapy. {iframe}https://medcitynews.com/2019/03/thermo-fisher-to-buy-gene-therapy-contract-manufacturer-brammer-bio-for-1-7b/?utm_campaign=MCN%20Daily%20Top%20Stories&utm_source=hs_email&utm_medium=email&utm_content=71131944&_hsenc=p2ANqtz-9OtByngy6WO87OiPCw-55UJd337c6oNyWUoIKYAESwe-i2Ca28aqmRFG1A1f6B-Akx-MdtpB6n1cDBGOhTXl-Xdxizgg&_hsmi=71131944{/iframe}

Read More
Successful Marketing and PR Strategies for Your Startup

Successful Marketing and PR Strategies for Your Startup

Successful Marketing and PR Strategies for Your Startup PR and Marketing – What’s the difference? How do you establish your brand? Are there tips…

Read More
Healthy Funding: The Critical Role of Investing in NIH to Boost Health and Lower Costs | ITIF

Healthy Funding: The Critical Role of Investing in NIH to Boost Health and Lower Costs | ITIF

NIH funding is critical to improving health outcomes and reducing the societal costs of illnesses. Congress should increase the NIH budget and then maintain…

Read More
Top 10 Immuno-Oncology Collaborations

Top 10 Immuno-Oncology Collaborations

A sampling of recent reports shows just how much immuno-oncology continues to grow. Last month, GrandView Research projected a more than doubling of the…

Read More